Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
- Conditions
- Follicular Lymphoma
- Registration Number
- NCT06049485
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Historically, participation in medical studies is highly skewed towards particular demographic groups of people.
This research will invite several participants to gather a wide range of information on clinical trial experiences for follicular lymphoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of follicular lymphoma.
The data collected from this study will help improve future outcomes for all follicular lymphoma patients as well as those in under-represented demographic groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Participant must be 18 years of age or older
- Patient has been diagnosed with follicular lymphoma
- Patient has access to a home internet connection in order to provide regular updates through the course of the study
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- Inability to provide written informed consent
- Patients receiving any other investigational agents
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who remain in a follicular lymphoma medical study to trial completion 12 months Number of patients who decide to enroll in a follicular lymphoma clinical research 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States